Aarvik Therapeutics, Inc. reported raising $8.33 Million in an initial SEC Form D filing, from an offering of $8.33 Million
Amount Raised
$8.33 Million
Round Type
Venture
HaywardBiotechnologyHealthcareHealth CareTherapeuticsresearchWho else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Aarvik Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- CytoDyn raised $2.9M (Seed) on September 16, 2021.
- PharmaCyte Biotech, Inc. raised $70M on September 1, 2021.
- Os Therapies raised $1M on September 1, 2021.
- ADARx Pharmaceuticals, Inc. raised $75M on August 17, 2021.
- Amylyx Pharmaceuticals raised $135M (Series C) on July 20, 2021.
- Century Therapeutics raised $11M on July 19, 2021.
Who to call at Aarvik Therapeutics, and when
A new round usually means Aarvik Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aarvik Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aarvik Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aarvik Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aarvik Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aarvik Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.